SCHEDULE 13G/A: Intracoastal Capital and Affiliates Disclose 4.99% Stake in INVO Fertility, Inc.

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has filed an amended Schedule 13G disclosing a beneficial ownership of 4.99% in INVO Fertility, Inc.'s common stock.

Summary

• Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in INVO Fertility, Inc.
• As of March 31, 2025, the Reporting Persons collectively beneficially owned 34,981 shares of INVO Fertility, Inc. common stock.
• This ownership represents approximately 4.99% of the company's common stock.
• The 34,981 shares consist of 15,333 shares issuable upon exercise of "Intracoastal Warrant 1" and 19,648 shares issuable upon exercise of "Intracoastal Warrant 2."
• The calculation of the 4.99% ownership is based on 666,058 shares of common stock outstanding as of March 18, 2025, as reported by the Issuer, plus the shares issuable from the two warrants.
• Intracoastal Warrant 2 contains a blocker provision that prevents exercise to the extent it would result in beneficial ownership exceeding 4.99% of the common stock, excluding an additional 9,769 shares that would otherwise be issuable.
• The Reporting Persons have shared voting and dispositive power over the 34,981 shares.
• The securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of INVO Fertility, Inc.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment. It simply reports a stake held by an investor group.

Positives

• NA

Negatives

• NA

Risks

• The beneficial ownership is capped at 4.99% due to a blocker provision in Intracoastal Warrant 2, which prevents the holder from exercising the warrant if it would result in ownership exceeding this threshold. This limits the potential for increased influence or ownership by the Reporting Persons.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of beneficial ownership by an institutional investor group in a publicly traded company within the fertility sector. Such filings provide transparency regarding significant shareholder positions but do not typically indicate strategic shifts or operational performance. The 4.99% stake is just below the 5% threshold that would trigger a more detailed Schedule 13D filing, which often implies an intent to influence or control the issuer.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant, but non-controlling, ownership stake by an institutional investor group. The blocker provision ensures the group remains below the 5% threshold, indicating no immediate intent to influence control.

Key Dates

Keywords

SEC filing, Schedule 13G, beneficial ownership, INVO Fertility Inc., common stock, warrants, institutional investor, equity stake, public disclosure